SOUTH EASTON, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. today announced that the Company will host a teleconference to discuss its second quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web- cast information is provided below:
Date: Thursday, August 14, 2008
Time: 4:30 p.m. Eastern Time (ET)
To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through September 15, 2008, and will be accessible through the Company's website: www.pressurebiosciences.com
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development, and commercialization, of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.
CONTACT: Investors, Richard T. Schumacher, President & CEO or Edward H.
Myles, Senior Vice President of Finance & CFO, both of Pressure
BioSciences, Inc., +1-508-230-1828
Web site: http://www.pressurebiosciences.com/
